此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Effect of Remote Ischaemic Preconditioning on Clinical Outcomes in CABG Surgery (ERICCA)

2015年5月28日 更新者:University College, London

Effect of Remote Ischaemic Preconditioning on Clinical Outcomes in Coronary Artery Bypass Graft Surgery

Coronary heart disease (CHD) is the leading cause of death in the UK, accounting for 124,000 deaths (2006) and costing the UK economy over £7.9 billion a year. Patients with severe CHD are usually treated by coronary artery bypass graft (CABG) surgery, the risks of which are increasing due to older and sicker patients being operated on. New treatment strategies are therefore required to improve health outcomes in these high-risk patients undergoing CABG with or without valve (CABG±valve) surgery.

The hypothesis tested in this research proposal is that remote ischaemic preconditioning (RIC), a virtually cost-free, non-pharmacological and simple non-invasive strategy for reducing the damage to the heart muscle at the time of surgery, improves health outcomes in high-risk patients undergoing CABG±valve surgery.

In this research project, 1610 high-risk patients undergoing CABG±valve surgery will be recruited via 28 UK hospitals performing heart surgery. Patients will be randomly allocated to receive either RIC or control. For RIC, a blood pressure cuff will be placed on the upper arm to temporarily deprive it of oxygen and nutrients, an intervention which has been shown in the investigators pilot studies to reduce damage to the heart muscle by up to 40% during CABG±valve surgery. The investigators will determine whether RIC can improve health outcomes in terms of better patient survival, less heart attacks and strokes, shorter hospital stay; less damage to the heart, kidney and brain during surgery; better heart function post-surgery and less chance of developing heart failure; better exercise tolerance and quality of life.

研究概览

研究类型

介入性

注册 (实际的)

1612

阶段

  • 第三阶段

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Blackpool、英国
        • Blackpool Victoria Hospital
      • Cambridge、英国
        • Papworth Hospital
      • Cardiff、英国
        • Cardiff & Vale University Health Board
      • Edinburgh、英国
        • Edinburgh Royal Infirmary
      • Glasgow、英国
        • Golden Jubilee Hospital
      • Harefield、英国
        • Harefield Hospital
      • Hull、英国
        • Castle Hill Hospital
      • Leicester、英国
        • Glenfield Hospital
      • London、英国
        • Royal Brompton Hospital
      • London、英国
        • St George's Hospital
      • London、英国
        • Hammersmith Hospital
      • London、英国
        • St Bartholomew's Hospital
      • London、英国
        • St Thomas Hospital
      • London、英国
        • Kings College London Hospital
      • London、英国
        • London Chest Hospital
      • London、英国
        • UCLH Heart Hospital
      • Manchester、英国
        • Manchester Royal Infirmary
      • Manchester、英国
        • Wythenshawe Hospital
      • Manchester、英国
        • John Radcliffe Hospital
      • Newcastle、英国
        • Freeman Hospital
      • Nottingham、英国
        • Trent Cardiac Centre
      • Plymouth、英国
        • Derriford Hospital
      • Sheffield、英国
        • Northern General Hospital
      • Southampton、英国
        • Southampton General Hospital
      • Swansea、英国
        • Swansea Hospital
      • Wolverhampton、英国
        • Wolverhampton Hospital
    • Essex
      • Basildon、Essex、英国
        • Essex cardiothoracic centre
    • Sussex
      • Brighton、Sussex、英国
        • Royal Sussex County Hospital

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  1. Patients undergoing CABG with or without valve surgery using blood cardioplegia
  2. Patients aged 18 years and above
  3. Patients with an additive Euroscore greater than or equal to 5

Exclusion Criteria:

  1. Cardiogenic shock
  2. Cardiac arrest on current admission
  3. Pregnancy
  4. Significant peripheral arterial disease affecting the upper limbs
  5. Patients with significant hepatic dysfunction (Prothrombin>2.0 ratio)
  6. Patients with significant pulmonary disease (FEV1<40% predicted)
  7. Patients with known renal failure with a GFR<30 mL/min/1.73 m2
  8. Patients on glibenclamide or nicorandil, as these medications may interfere with RIC
  9. Patients recruited into another study which may impact on the ERICCA study

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:单组作业
  • 屏蔽:三倍

武器和干预

参与者组/臂
干预/治疗
安慰剂比较:Control
Control treatment (sham RIC) will consist of four 5-minute simulated inflations of a blood pressure cuff placed on the upper arm. The inflations will be separated by 5-minute periods when the blood pressure cuff will be deflated.
Control treatment (sham RIC) will consist of four 5-minute simulated inflations of a blood pressure cuff placed on the upper arm. The inflations will be separated by 5-minute periods when the blood pressure cuff will be deflated.
有源比较器:Remote ischaemic conditioning
Blood pressure cuff placed on upper arm and inflated to 200mmHg for 5 minutes then deflated for 5 minutes - this cycle is repeated a total of 4 times.
Blood pressure cuff placed on upper arm and inflated to 200mmHg for 5 minutes then deflated for 5 minutes - this cycle is repeated a total of 4 times.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Major adverse cardiac and cerebral events
大体时间:One year post-surgery
Combined endpoint of Cardiovascular death, MI, Revascularisation and Stroke.
One year post-surgery

次要结果测量

结果测量
措施说明
大体时间
Peri-operative myocardial injury
大体时间:72 hours peri-operative period
72 hours area under curve serum troponin-T
72 hours peri-operative period
LV ejection fraction
大体时间:At one year
Echo determined LV ejection fraction
At one year
Acute kidney injury
大体时间:Peri-operative
Acute kidney injury score and 24 hour area under curve serum NGAL
Peri-operative
30 day MACCE
大体时间:30 days post surgery
Major adverse cardiac and cerebral events 30 days post surgery
30 days post surgery
All cause death
大体时间:1 year post surgery
1 year post surgery
Length of ITU stay
大体时间:ITU stay
ITU stay
Length of hospital stay
大体时间:Until hospital discharge
Until hospital discharge
Inotrope score
大体时间:72 hours post surgery
Inotrope score after 72 hours
72 hours post surgery
6 minute Walk Test
大体时间:6 weeks and 12 months post surgery
6 weeks and 12 months post surgery
Quality of Life
大体时间:6 weeks, 3/6/9 and 12 months post surgery
Quality of Life assessed using the EQ-5D measurement
6 weeks, 3/6/9 and 12 months post surgery

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Derek J Hausenloy, MD PhD、University College, London

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2010年11月1日

初级完成 (实际的)

2015年3月1日

研究完成 (实际的)

2015年3月1日

研究注册日期

首次提交

2010年11月22日

首先提交符合 QC 标准的

2010年11月23日

首次发布 (估计)

2010年11月24日

研究记录更新

最后更新发布 (估计)

2015年5月29日

上次提交的符合 QC 标准的更新

2015年5月28日

最后验证

2015年5月1日

更多信息

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅